Annual SG&A
$66.98 M
-$50.32 M-42.90%
31 December 2023
Summary:
Lyell Immunopharma annual selling, general & administrative expenses is currently $66.98 million, with the most recent change of -$50.32 million (-42.90%) on 31 December 2023. During the last 3 years, it has risen by +$20.10 million (+42.88%). LYEL annual SG&A is now -42.90% below its all-time high of $117.31 million, reached on 31 December 2022.LYEL Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$11.77 M
-$487.00 K-3.97%
30 September 2024
Summary:
Lyell Immunopharma quarterly selling, general & administrative expenses is currently $11.77 million, with the most recent change of -$487.00 thousand (-3.97%) on 30 September 2024. Over the past year, it has dropped by -$3.74 million (-24.11%). LYEL quarterly SG&A is now -65.81% below its all-time high of $34.42 million, reached on 31 March 2022.LYEL Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$4.33 B
-$203.99 M-4.95%
30 September 2024
Summary:
Lyell Immunopharma TTM selling, general & administrative expenses is currently -$4.33 billion, with the most recent change of -$203.99 million (-4.95%) on 30 September 2024. Over the past year, it has dropped by -$4.41 billion (-5497.25%). LYEL TTM SG&A is now -1194.85% below its all-time high of $122.83 million, reached on 30 September 2022.LYEL TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.9% | -24.1% | -5497.3% |
| 3 y3 years | +42.9% | -44.6% | -6104.8% |
| 5 y5 years | - | - | - |
LYEL Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -42.9% | +42.9% | -65.8% | at low | -158.2% | at low |
| 5 y | 5 years | -42.9% | +71.1% | -65.8% | +32.5% | -1194.8% | at low |
| alltime | all time | -42.9% | +71.1% | -65.8% | +32.5% | -1194.8% | at low |
Lyell Immunopharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $11.77 M(-4.0%) | $50.69 M(-6.9%) |
| June 2024 | - | $12.26 M(-9.2%) | $54.42 M(-11.1%) |
| Mar 2024 | - | $13.49 M(+2.5%) | $61.20 M(-8.6%) |
| Dec 2023 | $66.98 M(-42.9%) | $13.17 M(-15.1%) | $66.98 M(-16.4%) |
| Sept 2023 | - | $15.51 M(-18.5%) | $80.16 M(-11.7%) |
| June 2023 | - | $19.03 M(-1.3%) | $90.74 M(-11.2%) |
| Mar 2023 | - | $19.28 M(-26.8%) | $102.17 M(-12.9%) |
| Dec 2022 | $117.31 M | $26.35 M(+1.0%) | $117.31 M(-4.5%) |
| Sept 2022 | - | $26.08 M(-14.3%) | $122.83 M(+4.1%) |
| June 2022 | - | $30.45 M(-11.5%) | $117.99 M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $34.42 M(+8.0%) | $106.65 M(+19.8%) |
| Dec 2021 | $89.06 M(+90.0%) | $31.87 M(+50.1%) | $89.06 M(+23.6%) |
| Sept 2021 | - | $21.24 M(+11.1%) | $72.05 M(+11.9%) |
| June 2021 | - | $19.11 M(+13.6%) | $64.38 M(+17.4%) |
| Mar 2021 | - | $16.83 M(+13.2%) | $54.83 M(+17.0%) |
| Dec 2020 | $46.88 M(+19.7%) | - | - |
| Dec 2020 | - | $14.87 M(+9.6%) | $46.88 M(+46.4%) |
| Sept 2020 | - | $13.57 M(+41.9%) | $32.01 M(+73.6%) |
| June 2020 | - | $9.56 M(+7.7%) | $18.44 M(+107.7%) |
| Mar 2020 | - | $8.88 M | $8.88 M |
| Dec 2019 | $39.15 M | - | - |
FAQ
- What is Lyell Immunopharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Lyell Immunopharma?
- What is Lyell Immunopharma annual SG&A year-on-year change?
- What is Lyell Immunopharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly SG&A year-on-year change?
- What is Lyell Immunopharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Lyell Immunopharma?
- What is Lyell Immunopharma TTM SG&A year-on-year change?
What is Lyell Immunopharma annual selling, general & administrative expenses?
The current annual SG&A of LYEL is $66.98 M
What is the all time high annual SG&A for Lyell Immunopharma?
Lyell Immunopharma all-time high annual selling, general & administrative expenses is $117.31 M
What is Lyell Immunopharma annual SG&A year-on-year change?
Over the past year, LYEL annual selling, general & administrative expenses has changed by -$50.32 M (-42.90%)
What is Lyell Immunopharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of LYEL is $11.77 M
What is the all time high quarterly SG&A for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly selling, general & administrative expenses is $34.42 M
What is Lyell Immunopharma quarterly SG&A year-on-year change?
Over the past year, LYEL quarterly selling, general & administrative expenses has changed by -$3.74 M (-24.11%)
What is Lyell Immunopharma TTM selling, general & administrative expenses?
The current TTM SG&A of LYEL is -$4.33 B
What is the all time high TTM SG&A for Lyell Immunopharma?
Lyell Immunopharma all-time high TTM selling, general & administrative expenses is $122.83 M
What is Lyell Immunopharma TTM SG&A year-on-year change?
Over the past year, LYEL TTM selling, general & administrative expenses has changed by -$4.41 B (-5497.25%)